FDA-PDS Symposium IV: Project Data Sphere, LLC & NCTN Data Archive Initiative


The Promise of Shared Data
Janet Woodcock, MD, Director, Center for Drug Evaluation and Research, FDA

Main Sessions

Leveraging the Power of Collaboration: FDA’s New Oncology Center of Excellence

  • Martin Murphy, DMedSc, PhD, FASCO, Project Data Sphere
  • Richard Pazdur, MD, FDA

Project Data Sphere Initiative Update: Outcomes Since Symposium III

  • Martin Murphy, Project Data Sphere
  • Mace Rothenberg, MD, Pfizer Oncology

Privacy Preserving Protocols for Sharing Sensitive Data

  • Andrew Lo, PhD, Massachusetts Institute of Technology

Immuno-Oncology: Overview of the Landscape — Present and Future

  • Peter Kolchinsky, PhD, RA Capital
  • Ramy Ibrahim, MD, Parker Institute for Cancer Immunotherapy


Alliance for Clinical Trials in Oncology

Amgen, Inc.

Astellas Pharma


Bayer HealthCare Pharmaceuticals, Inc.

Bristol-Myers Squibb

Celgene Corp.

Children’s Oncology Group

Critial Path Institute

Duke University School of Medicine

EMD Serono

Georgetown University


Helsinn Healthcare SA

Helsinn Therapeutics (U.S.), Inc.

Hogan Lovells US LLP

Laura and John Arnold Foundation

Massachusetts General Hospital

Memorial Sloan Kettering Cancer Center

Merck & Co., Inc.

RA Capital Management


Shanghai Institute for Biological Sciences

Takeda Oncology

The Leukemia & Lymphoma Society

Tulane University School of Medicine

UNC Lineberger Comprehensive Cancer Center